IRD

Opus Genetics, Inc. Common Stock

5.18

USD

-0.10

-1.89%

Sep 18, 15:59 UTC -4

Closed

After-Market

5.25

+0.07

+1.25%

Opus Genetics, Inc. Common Stock Profile

About

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

Info & Links

CEO

George Magrath

Headquarters

8 Davis Drive, Suite 220
Durham, NC 27713, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

Opus Genetics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

436.36M

Enterprise Value

382.48M

Enterprise Value/EBITDA(ttm)

-7.57

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

43.44

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-937.23%

Profit Margin(ttm)

-1276.30%

Return on Equity(ttm)

-338.88%

Return on Invested Capital(ttm)

-249.68%

Return on Assets(ttm)

-150.13%

Income Statement

Revenue(ttm)

9.86M

Revenue Per Share(ttm)

0.12

Gross Profit(ttm)

9.86M

EBITDA(ttm)³

-50.55M

Net Income Available to Common(ttm)

-107.61M

Diluted EPS(ttm)

-1.35

Share Statistics

Beta (5Y Monthly)

0.58

52-Week Change

262.24%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

83.20M

Dividend Yield

0.00%

Float⁴

72.98M

% Held by Insiders

11.70%

% Held by Institutions

14.97%

Balance Sheet

Total Cash(mrq)

88.81M

Total Cash Per Share(mrq)

1.07

Total Debt(mrq)

34.93M

Total Debt/Equity(mrq)

-269.00%

Current Ratio(mrq)

12.19%

Quick Ratio(mrq)

12.19%

Book Value Per Share(mrq)

-0.16

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.22

Free Cash Flow(ytd)

-24.68M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IRD